The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Alfa Wassermann competitive analysis

Loading summary...

Latest patents of Alfa Wassermann opposed by its competitors

Explore Alfa Wassermann's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2618819
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
EP2560662
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
EP2059232
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Latest PTAB cases involving Alfa Wassermann

Discover the latest PTAB cases involving Alfa Wassermann, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Alfa Wassermann with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALFA WASSERMANN - 6 - -
BOTTI & FERRARI14 - - -
GENERICS UK214 - - -
SANDOZ1191619 -